A randomised controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery.

J. Farkas,C. Chapuis,S. Combe,M. Silsiguen,J. Marzelle,C. Laurian,J. Cormier
DOI: https://doi.org/10.1016/S0950-821X(05)80369-X
1993-09-01
European Journal of Vascular Surgery
Abstract:
What problem does this paper attempt to address?